
Sign up to save your podcasts
Or


We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.
By Retina Synthesis4.5
88 ratings
We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.

43 Listeners

18 Listeners

99 Listeners

113,168 Listeners

56,921 Listeners

5 Listeners

9,558 Listeners

12 Listeners

47,696 Listeners

51 Listeners

11 Listeners

467 Listeners

19 Listeners

0 Listeners